Stock Market News2 weeks Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva Zacks
AXSM stock rises 20% as it settles Auvelity patent litigation with Teva, protecting the drug’s exclusivity in the United States at least until Sept. 30, 2038.
XAXSM stock rises 20% as it settles Auvelity patent litigation with Teva, protecting the drug’s exclusivity in the United States at least until Sept. 30, 2038.
X